Psychiatric distress and health-related quality of life in obesity.

Diabetes Nutr Metab

Metabolic Unit, Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy.

Published: June 2003

Unlabelled: Health-related quality of life (HRQL) is poor in obese patients and not necessarily related to the severity of disease. In a large proportion of patients psychopathological distress is also present and its role on poor HRQL has never been quantified.

Methods: In 207 patients entering a University-based weight-reducing programme (38 males, 169 females), a package of self-administered questionnaires was submitted to measure HRQL (Short-Form 36) and psychopathological distress [general: Symptom Check-List 90 (SCL-90); depression: Beck Depression Inventory (BDI); binge eating: Binge Eating Scale (BES)]. Several clinical and anthropometric data were also recorded.

Results: HRQL, both in its physical and mental component, was significantly reduced in obesity when related to Italian population norms. SCL-90 identified psychopathological distress in 53 patients (26%), the BDI was indicative of depression in 89 cases (43%), whereas high scores of the BES were measured in 88 cases. Logistic regression analysis identified psichopathological distress as the major factor associated with poor HRQL.

Conclusions: Psychiatric disturbances significantly contribute to poorly perceived health status. Only a comprehensive treatment including a specific approach to psychiatric symptoms may be effective in improving the perceived health status of obese patients seeking treatment.

Download full-text PDF

Source

Publication Analysis

Top Keywords

psychopathological distress
12
health-related quality
8
quality life
8
obese patients
8
binge eating
8
perceived health
8
health status
8
patients
5
psychiatric distress
4
distress health-related
4

Similar Publications

: Takotsubo syndrome (TTS) shares many clinical features with acute myocardial infarction (AMI); however, its underlying pathophysiology remains elusive due to specific characteristics (i.e., reversibility, presence of stressors, and low mortality rate).

View Article and Find Full Text PDF

Objectives: The study's aim was to determine co-occurrence of psychopathological symptoms and personality predispositions in post-traumatic stress disorder (PTSD) and its dimensions several months after hospitalisation of patients with severe COVID-19 during the 2nd and 3rd waves of the epidemic.

Methods: At 7-8 months after admission, 138 patients completed the PCL-5 and TIPI questionnaires, as well as the HADS and AIS scales. Correlation analysis and stepwise multiple regression analysis were used in the models.

View Article and Find Full Text PDF

What is the Best Approach to Removing the Social Stigma from the Diagnosis of Gender Dysphoria?

Health Care Anal

January 2025

Department of Endocrinology, Diabetes, and Metabolism, 'Elena Venizelou' General Hospital, Elena Venizelou Square 2, Athens, 11521, Greece.

Historically, the transgender population has faced prejudice and discrimination within society. The purpose of diagnostic terms is to direct clinical care and facilitate insurance coverage. However, the existence of a medical diagnosis for gender nonconformity can exacerbate the stigmatization of transgender people with adverse consequences on their emotional health and social life.

View Article and Find Full Text PDF
Article Synopsis
  • The COVID-19 pandemic has heightened psychological distress, with factors like childhood trauma and maladaptive personality traits contributing to mental health issues.
  • A study of 6,451 adults identified key connections between childhood trauma, maladaptive traits, and increased psychopathological symptoms, using self-reported measures and structural equation modeling.
  • Findings suggest that targeting emotion dysregulation and mentalizing may be beneficial in developing interventions to alleviate pandemic-related psychological distress, especially for those with childhood trauma and maladaptive traits.
View Article and Find Full Text PDF

An exploratory study of the safety profile and neurocognitive function after single doses of mitragynine in humans.

Psychopharmacology (Berl)

December 2024

Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, P.O. Box 616, Maastricht, 6200 MD, The Netherlands.

Rationale: Despite the growing scientific interest on mitragynine, the primary alkaloid in kratom (Mitragyna Speciosa), there is a lack of clinical trials in humans.

Objectives: This phase 1 study aimed to evaluate mitragynine's safety profile and acute effects on subjective drug experience, neurocognition, and pain tolerance.

Methods: A placebo-controlled, single-blind, within-subjects study was conducted in two parts.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!